← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2013Last known activity
Aug 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 5 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (10)
- NCT06960759Lead sponsorPhase 2Aug 1, 2025
- NCT06960759OfficialPhase 2Aug 1, 2025
- NCT06960759Sponsor investigatorPhase 2Aug 1, 2025
- NCT05302804Overall official - principal investigatorPhase 4May 1, 2022
- NCT04256733Reponsible party - principal investigatorPhase 1May 1, 2019
- NCT04256733Lead sponsorPhase 1May 1, 2019
- NCT04256733Overall official - principal investigatorPhase 1May 1, 2019
- NCT04456608CollaboratorPhase 4Aug 1, 2016
- NCT01902758Lead sponsorPhase 2/Phase 3Aug 1, 2013
- NCT01902758Reponsible party - principal investigatorPhase 2/Phase 3Aug 1, 2013
Details
- Last known activity
- Aug 1, 2025